Skip to main content
SpringerLink
Log in

Eicosanoid production in rheumatoid synovitis

  • Inflammation and Immunomodulation
  • Meeting Report
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Leukotriene B4 (LTB4) synthesis in rheumatoid synovitis was studied using peripheral and synovial fluid polymorphonuclear leukocytes (PMNs) and rheumatic synovial lining cells. No differences were found in LTB4 synthesis between peripheral PMNs from healthy volunteers and rheumatoid arthritis patients. When peripheral and synovial PMNs from the same RA patient were compared, arachidonic acidinduced LTB4 synthesis in synovial fluid PMNs was increased 1.7–7.2 fold, whereas the response to Ca ionophore A23187 stimulation was similar. This suggests 5-lipoxygenase stimulating factor(s) in inflamed joints. Rheumatic synovial lining cells in a primary cell culture produced small amounts of LTB4, the concentrations being less than 0.1 per cent of those of prostaglandin E2 (PGE2). PGE2 synthesis in synovial cells was increased when arachidonic acid or interleukin-1 was added to the culture, whereas LTB4 production remained unaltered. The present results suggest that in inflamed joints LTB4 originates mainly from PMNs whereas synovial lining cells are the source for PGE2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. M. A. Bray,Leukotrienes in inflammation. Agents and Actions19, 87–99 (1986).

    PubMed  Google Scholar 

  2. C. W. Parker,Lipid mediators produced through the lipoxygenase pathway. Ann. Rev. Immunol.5, 65–84 (1987).

    Google Scholar 

  3. J. A. Salmon and G. A. Higgs,Prostaglandins and leukotrienes as inflammatory mediators. Br. med. Bull.43, 285–296 (1987).

    PubMed  Google Scholar 

  4. L. B. Klickstein, C. Shapleigh and E. J. Goetzl,Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondylarthritis. J. clin. Invest.66, 1166–1170 (1980).

    PubMed  Google Scholar 

  5. E. M. Davidson, S. A. Rae and M. J. H. Smith,Leukotriene B 4,a mediator of inflammation present in synovial fluid in rheumatoid arthritis. Ann. rheum. Dis.42, 677–679 (1983).

    PubMed  Google Scholar 

  6. B. Henderson and G. A. Higgs,Synthesis of arachidonate oxidation products by synovial joint tissues during the development of chronic erosive arthritis. Arthritis Rheum.30, 1149–1156 (1987).

    PubMed  Google Scholar 

  7. M. K. B. McGuire, J. E. Meats, N. M. Ebsworth, L. Harvey, G. Murphy, R. G. G. Russell and J. J. Reynolds,Properties of rheumatoid and normal synovial tissue in vitro and cells derived from them. Rheumatol. Int.2, 113–120 (1982).

    PubMed  Google Scholar 

  8. E. Moilanen, E. Seppälä, M. Nissilä and H. Vapaatalo,Differences in prostanoid production between healthy and rheumatic synovia in vitro. Agents and Actions20, 98–103 (1987).

    PubMed  Google Scholar 

  9. A. Bøyum,Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. suppl.5, 9–15 (1976).

    Google Scholar 

  10. E. Moilanen, J. Alanko, E. Seppälä and H. Vapaatalo,Effects of antirheumatic drugs on leukotriene B 4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro. Agents and Actions24, 387–394 (1988).

    PubMed  Google Scholar 

  11. O. H. Lowry, N. J. Rosebrough, A. I. Farr, and R. J. Randall,Protein measurement with the Folin phenol reagent. J. biol. Chem.193, 265–275 (1951).

    PubMed  Google Scholar 

  12. F. J. Zijlstra and J. E. Vincent,Determination of leukotrienes and prostaglandins in (14C)arachidonic acid labelled human lung tissue by high-performance liquid chromatography and radioimmunoassay. J. Chromatogr.311, 39–50 (1984).

    PubMed  Google Scholar 

  13. J. A. Salmon, P. M. Simmons and R. M. J. Palmer,A radioimmunoassay for leukotriene B 4. Prostaglandins24, 225–235 (1982).

    PubMed  Google Scholar 

  14. S. Shak and I. M. Goldstein.The major pathway for leukotriene B 4 catabolism in human polymorphonuclear leukocytes involves ω-oxidation by a cytochrome P-450 enzyme. InProstaglandins, leukotrienes and lipoxins. (Ed. J. M. Bailey) pp. 97–109, Plenum Press, New York 1985.

    Google Scholar 

  15. P. D. L. Maurice, R. D. R. Camp and B. R. Allen,The metabolism of leukotriene B 4 by peripheral blood polymorphonuclear leukocytes in psoriasis. Prostaglandins33, 807–818 (1987).

    PubMed  Google Scholar 

  16. E. Seppälä, O. Pora and T. Metsä-Ketelä,A modified method for extraction and purification of prostaglandins with resin XAD-2. Prostaglandins Leukotrienes Med.14, 235–241 (1984).

    Google Scholar 

  17. P. M. Simmons, J. A. Salmon and S. Moncada,The release of leukotriene B 4 during experimental inflammation. Biochem. Pharmacol.32, 1353–1359 (1983).

    PubMed  Google Scholar 

  18. D. G. Payan, A. Missirian-Bastian and E. J. Goetzl,Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B 4. Proc. natn. Acad. Sci. USA81, 3501–3505 (1984).

    Google Scholar 

  19. N. Gualde, D. Atluru and J. S. Goodwin,Effect of lipoxygenase metabolites of arachidonic acid on proliferation of human T cells and T cell subsets. J. Immunol.134, 1125–1129 (1985).

    PubMed  Google Scholar 

  20. M. Rola-Pleszczynski,Differential effects of leukotriene B 4 on T4 + and T8 + lymphocyte phenotype and immunoregulatory functions. J. Immunol.135, 1357–1360 (1985).

    PubMed  Google Scholar 

  21. D. Atluru and J. S. Goodwin,Control of polyclonal immunoglobulin production from human lymphocytes by leukotrienes; leukotriene B 4 induces an OKT8(+) radiosensitive suppressor cell from resting human OKT8(−) T cells. J. clin. Invest.74, 1444–1450 (1984).

    PubMed  Google Scholar 

  22. J. L. Ambrus, C. H. Jurgensen, N. L. Witzel, R. A. Lewis, J. L. Butler and A. S. Fauci,Leukotriene C 4 produced by a human T-T hybrinoma suppresses Ig production by human lymphocytes. J. Immunol.140, 2382–2388 (1988).

    PubMed  Google Scholar 

  23. C. R. Pace-Asciak and W. L. Smith,Enzymes in the biosynthesis and catabolism of the eicosanoids: prostaglandins thromboxanes, leukotrienes and hydroxy fatty acids. InThe Enzymes, vol. 16 (Ed. P. D. Boyer) pp. 543–603, Academic Press, New York 1983.

    Google Scholar 

  24. R. M. McMillan, D. J. Masters, W. W. Sterling and P. R. Bernstein,Biosynthesis of leukotriene B 4 in human leukocytes. Demonstration of a calcium-dependent 5-lipoxygenase. InProstaglandins, leukotrienes and lipoxins. (Ed. J. M. Bailey) pp. 655–668 Plenum Press, New York 1985.

    Google Scholar 

  25. M. Braquet, R. Ducousso, M.-Y. Chapelat, P. Borgeat and P. Braquet,Transmembrane signal in the secretory process of A23187-stimulated human leukocytes. InProstaglandins, leukotrienes and lipoxins. (Ed. J. M. Bailey) pp. 125–132, Plenum Press, New York 1985.

    Google Scholar 

  26. R. J. Smith, D. E. Epps, J. M. Justen, L. M. Sam, M. A. Wynalda, F. A. Fitzpatrick and F. S. Yein,Human neutrophil activation with interleukin-1. Biochem. Pharmacol.36, 3851–3858 (1987).

    PubMed  Google Scholar 

  27. R. Roubin, P. P. Elsas, W. Fiers and A. J. Dessein,Recombinant human tumour necrosis factor (rTNF) 2 enhances leukotriene biosynthesis in neutrophils and eosinophils stimulated with the Ca 2+ ionophore A23187. Clin. exp. Immunol.70, 484–490 (1987).

    PubMed  Google Scholar 

  28. J. Elmgreen, O. H. Nielsen and I. Ahnfelt-Rønne,Enhanced capacity for release of leucotriene B 4 by neutrophils in rheumatoid arthritis. Ann. rheum. Dis.46, 501–505 (1987).

    PubMed  Google Scholar 

  29. J. S. Bomalaski, M. A. Clark, S. D. Douglas and R. B. Zurier,Enhanced phospholipase A 2 and C activities of peripheral blood polymorphonuclear leukocytes from patients with rheumatoid arthritis. J. Leukocyte Biol.38, 649–654 (1985).

    PubMed  Google Scholar 

  30. S. M. Krane,Mechanisms of tissue destruction in rheumatoid arthritis. InArthritis and allied conditions, 10th edition. (Ed. D. J. McCarty) pp. 593–604, Lea and Febiger, Philadelphia 1985.

    Google Scholar 

  31. F. Blotman, J. Chaintreuil, P. Poubelle, O. Flandre, A. Crastes de Paulet and L. Simon,PGE 2,PGF 2α and TXB 2 biosynthesis by human rheumatoid synovia. InAdv. Prostaglandin Thromboxane Res, vol. 8 (Eds. B. Samuelsson, P. W. Ramwell and R. Paoletti) pp. 1705–1708, Raven Press, New York 1980.

    Google Scholar 

  32. J. A. Salmon, G. A. Higgs, J. R. Vane, L. Bitensky, J. Chayen, B. Henderson and B. Cashman,Synthesis of arachidonate cyclo-oxygenase products by rheumatoid and nonrheumatoid synovial lining in nonproliferative organ culture. Ann. rheum. Dis.42, 36–39 (1983).

    PubMed  Google Scholar 

  33. J. T. Du, M. Foegh, Y. Maddox and P. W. Ramwell,Human peritoneal macrophages synthetize leukotrienes B 4 and C 4. Biochem. biophys. Acta753, 159–163 (1983).

    PubMed  Google Scholar 

  34. R. J. T. Ouwendijk, F. J. Zijlstra, J. H. P. Wilson, J. E. Vincent and I. L. Bonta,Production of leukotrienes and prostaglandins by human ascites cells. Eur. J. clin. Invest.15, 327–331 (1985).

    PubMed  Google Scholar 

  35. A. O. S. Fels, N. A. Pawlowski, E. B. Cramer, T. K. C. King, Z. A. Cohn and W. A. Scott,Human alveolar macrophages produce leukotriene B 4. Proc. natn. Acad. Sci. USA79, 7866–7870 (1982).

    Google Scholar 

  36. T. R. Martin, L. C. Altman, R. K. Albert and W. R. Henderson,Leukotriene B 4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am. Rev. respir. Dis.129, 106–111 (1984).

    PubMed  Google Scholar 

  37. E. A. Ham, D. D. Soderman, M. E. Zanetti, H. W. Dougherty, E. McCauley and F. A. Kuehl,Inhibition by prostaglandins of leukotriene B 4 release from activated neutrophils. Proc. natn. Acad. Sci. USA80, 4349–4353 (1983).

    Google Scholar 

  38. G. R. Elliot, J. Lauwen and I. L. Bonta,Exogenous arachidonic acid inhibits A23187 stimulated macrophage leukotriene B 4 synthesis in vitro. Agents and Actions23, 84–85 (1988).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences, University of Tampere, P.O. Box 607, 33101, Tampere, Finland

    E. Moilanen, J. Alanko & H. Vapaatalo

  2. Rheumatism Foundation Hospital, 18120, Heinola, Finland

    M. Nissilä, M. Hämäläinen & H. Isomäki

Authors
  1. E. Moilanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Alanko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Nissilä
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Hämäläinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Isomäki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Vapaatalo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moilanen, E., Alanko, J., Nissilä, M. et al. Eicosanoid production in rheumatoid synovitis. Agents and Actions 28, 290–297 (1989). https://doi.org/10.1007/BF01967417

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01967417

Keywords

Search

Navigation